Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers

This study was a phase 1, single-center, randomized, double-blind, placebo-controlled, single-dosing, and dose-escalating study of intravenous SAL200. It is a new candidate drug for the treatment of antibiotic-resistant staphylococcal infections based on a recombinant form of the phage endolysin SAL...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Antimicrob Agents Chemother
Huvudupphovsmän: Jun, Soo Youn, Jang, In Jin, Yoon, Seonghae, Jang, Kyungho, Yu, Kyung-Sang, Cho, Joo Youn, Seong, Moon-Woo, Jung, Gi Mo, Yoon, Seong Jun, Kang, Sang Hyeon
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2017
Ämnen:
Clinical Therapeutics
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444177/
https://ncbi.nlm.nih.gov/pubmed/28348152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02629-16
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk